Library / Laws / 118th / hr / H.R. 6003 / Introduced in House
I
118th CONGRESS
1st Session
H. R. 6003
IN THE HOUSE OF REPRESENTATIVES
October 19, 2023Ms. Porter (for herself, Ms. Barragán, Mr. Doggett, Ms. Jayapal, Mr. Johnson of Georgia, Ms. Norton, Ms. Scanlon, Mr. Tonko, Mr. Mullin, Mr. Neguse, Ms. Tlaib, Ms. Chu, Ms. Meng, Ms. Castor of Florida, Mrs. Foushee, Mr. Krishnamoorthi, Mr. Jackson of Illinois, Ms. Spanberger, Ms. Omar, Mr. Grijalva, Mr. Pocan, Ms. Clarke of New York, Mr. McGovern, and Ms. Lee of California) introduced the following bill
October 25, 2023Referred to the Committee on Financial Services
A BILL
To amend the Fair Credit Reporting Act to prohibit the inclusion of medical debt on a consumer report, and for other purposes.
1.
Short title
This Act may be cited as the Medical Debt Relief Act of 2023.
2.
Amendments to Fair Credit Reporting Act
(a)
Medical debt defined
Section 603 of the Fair Credit Reporting Act (15 U.S.C. 1681a) is amended by adding at the end the following:
(bb)
Medical debt
The term medical debt means a debt related to, in whole or in part, transactions, accounts, or balances arising from the receipt of medical services, products, or devices.
.
(b)
Exclusion for medical debt
Section 605(a) of the Fair Credit Reporting Act (15 U.S.C. 1681c(a)) is amended by adding at the end the following:
(9) Any adverse information related to a medical debt, including a medical debt that was placed for collection, charged to profit or loss, or subjected to any similar action.
.
3.
Modification of regulations relating to prohibitions on use of medical debt information
(a)
Definitions
In this section, the terms credit and creditor have the meanings given those terms in section 702 of the Equal Credit Opportunity Act (15 U.S.C. 1691a).
(b)
Requirement
Not later than 1 year after the date of enactment of this Act, the Director of the Bureau of Consumer Financial Protection shall amend section 1022.30 of title 12, Code of Federal Regulations, or any successor regulation, to ensure that creditors are prohibited from obtaining or using information relating to the medical debt of a consumer in determining whether or not to extend credit to that consumer.